Skip to content

Comparison Efficacy and Safety of Koklan Mixture Formula 3 and Diclofenac for Relieving Pain in Primary Knee Osteoarthritis

Comparison Efficacy and Safety of Koklan Mixture Formula 3 and Diclofenac for Relieving Pain in Primary Knee Osteoarthritis

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20201020010
Enrollment
Unknown
Registered
2020-10-20
Start date
2020-10-12
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis is a very common disease in the elderly society. Changes in the articular cartilage cause knee deterioration&#44

Interventions

The KoKlan Mixture Formula 3 IS a National Drug Information from Thai traditional medicine and has sufficient scientific data of pharmacology properties supporting the pain relieving&#44
inflammatory results and clinical study also showed support for the safety of using this medicine instead of NSAIDs. KoKlan (Scientific Name: Mallotus Repandus (Willd.) Mull.Arg. Family: Euphorbiacea
inflammatory and analgesic,In general&#44
Diclofenac&#44
which belongs to NSAIDs&#44
has analgesic and anti&#45
inflammatory effects. Although Diclofenac is often prescribed&#44
it conveys high incidences of side effects especially in stomach ulcers.
Experimental Drug,Active Comparator Drug
Koklan Mixture Formula 3 ,Diclofenac

Sponsors

Mrs.Renu pongsaree
Lead Sponsor
SUAN SUNANDHA RAJABHAT UNIVERSITY
Collaborator

Eligibility

Sex/Gender
All
Age
50 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) age between 50-70 years old, no sex limitation. 2)Has diagnosed with Primary-KOA by modern medicine doctor and Thai Tradition medicine doctor and Oxford Knee Score with pain level 1-2 (score of 20-39.) This is a mild to moderate pain level. 3)No personal severe chronic disease: ulcer, heart, liver, lung, or kidney diseases. 4) Does not take NSAID pain reliever in the last 1 week before participates in the project.

Exclusion criteria

Exclusion criteria: 1) History of medical allergy used during investigation 2) Severe knee osteoarthritis and currently using NSAIDs

Design outcomes

Primary

MeasureTime frame
Pain relieving 1,3,7,14,21 days Comparision of KoKlan Mixture Formula 3 and Diclofenac

Secondary

MeasureTime frame
Efficacy and Safety 14 days Oxford Knee Score ,WOMAC, Knee range of motion, laboratory blood

Contacts

Public ContactRenu Pongsaree

Graduate School , Suansunandha Rajabhat University

renu622009@gmail.com0816365809

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026